-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Colorectal cancer (CRC) is the world's third most common cancer and the second largest cause of cancer-related deaths.
Colorectal cancer (CRC) is the world's third most common cancer and the second largest cause of cancer-related deaths.
Although the fecal hemoglobin immunochemical test has proven to be an effective and usable non-invasive test that can be used to screen for the risk of CRC, its sensitivity for detecting advanced adenoma or stage I CRC is limited
Immune screening
Previous studies have shown that the level of microRNA (miRNA) in the blood is related to the occurrence and development of CRC
The level of microRNA (miRNA) in the blood is related to the occurrence and development of CRC
Participant screening related flowchart
Participant screening related flowchartIn this study, the researchers derived a blood-based miRNA scoring system and evaluated its ability to predict the occurrence and development of CRC in adults aged 50-75
In this study, the researchers derived a blood-based miRNA scoring system and evaluated its ability to predict the occurrence and development of CRC in adults aged 50-75
CRC risk prediction
CRC risk predictionThe researchers constructed a 7-miRNA scoring system through logistic regression and evaluated the predictive ability of the system, with an AUC value of 0.
A microRNA panel compared to environmental and polygenic scores for colorectal cancer risk prediction
Leave a message here